Trademark Search in Canada

RINREYA

View On IC.GC.CA

SEARCHED

on 5 Feb 2025

Last Applicant/ Owned by

Takeda Pharmaceuticals International AG

Thurgauerstrasse 130CH-8152 Glattpark-Opfikon

Serial Number

2308059 filed on 27^th Nov 2023

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

K1P1C3

RINREYA

Trademark usage description

produits pharmaceutiques; préparations pharmaceutiques pour le traitement des crises de convulsions associées au syndrome de dravet et au syndrome de Read More

Classification Information

Class [005]
Produits pharmaceutiques; préparations pharmaceutiques pour le traitement des crises de convulsions associées au syndrome de Dravet et au syndrome de Lennox-Gastaut.

Classification kind code

Mark Details

Serial Number

2308059

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 11^th Feb 2025	Agent Changed
Submitted for opposition 22 on 5^th Feb 2025	Search Recorded
Submitted for opposition 20 on 5^th Feb 2025	Examiner's First Report
Submitted for opposition 223 on 5^th Feb 2025	Total Provisional Refusal
Submitted for opposition 256 on 2^th Dec 2024	Notification of Possible Opposition Sent
Submitted for opposition 257 on 1^st Feb 2024	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 31^st Jan 2024	Formalized
Submitted for opposition 1 on 31^st Jan 2024	Created
Submitted for opposition 228 on 27^th Nov 2023	International Registration
Submitted for opposition 30 on 27^th Nov 2023	Filed

RINREYA

Classification Information

Class [005]Produits pharmaceutiques; préparations pharmaceutiques pour le traitement des crises de convulsions associées au syndrome de Dravet et au syndrome de Lennox-Gastaut.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Produits pharmaceutiques; préparations pharmaceutiques pour le traitement des crises de convulsions associées au syndrome de Dravet et au syndrome de Lennox-Gastaut.